Log in to save to my catalogue

Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy

Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9277254

Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy

About this item

Full title

Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2022-07, Vol.113 (7), p.2425-2433

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The clinical significance of intraductal carcinoma of the prostate (IDC‐P) in men with nonmetastatic prostate cancer (PCa) treated with high‐dose external‐beam radiation therapy remains unclear. The aim of this study was to evaluate the impact of IDC‐P in men who received intensity‐modulated radiation therapy (IMRT) for nonmetastatic PCa. All patie...

Alternative Titles

Full title

Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9277254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9277254

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15392

How to access this item